Alec Stranahan
Stock Analyst at B of A Securities
(0.72)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Upgrades: Buy | 42 42 | 16.8 | 150% | 1 | Mar 28, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Neutral | 14 12 | 4.74 | 153.16% | 5 | Mar 5, 2025 | |
CADL Candel Therapeutics | Initiates Coverage On: Buy | 15 | 4.9 | 206.12% | 1 | Feb 7, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 28 25 | 6.47 | 286.4% | 4 | Jan 7, 2025 | |
CRBU Caribou Biosciences | Maintains: Buy | 13 11 | 1.29 | 752.71% | 1 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 5 | 1.29 | 287.6% | 2 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 6 | 3.75 | 60% | 2 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 2.27 | 560.79% | 1 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 36.92 | 48.97% | 3 | Jul 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 6.37 | 182.57% | 3 | Jun 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 138.96 | 0.75% | 3 | May 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 8.16 | 414.71% | 1 | May 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 36.74 | -83.67% | 2 | Dec 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 1.22 | 309.84% | 1 | Dec 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 46.98 | -4.21% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |